126 related articles for article (PubMed ID: 11783706)
1. Early-stage elephantiasis in bancroftian filariasis.
Grobusch MP; Göbels K; Teichmann D; Bergmann F; Suttorp N
Eur J Clin Microbiol Infect Dis; 2001 Nov; 20(11):835-6. PubMed ID: 11783706
[No Abstract] [Full Text] [Related]
2. Single-Dose Triple-Drug Therapy for
King CL; Weil GJ; Kazura JW
N Engl J Med; 2020 May; 382(20):1956-1957. PubMed ID: 32402169
[No Abstract] [Full Text] [Related]
3. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
4. Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: follow-up after re-treatment with the combination.
Dunyo SK; Simonsen PE
Trans R Soc Trop Med Hyg; 2002; 96(2):189-92. PubMed ID: 12055812
[TBL] [Abstract][Full Text] [Related]
5. Lymphatic Filariasis.
Madanchi M; Itin P
N Engl J Med; 2024 May; 390(18):e43. PubMed ID: 38708851
[No Abstract] [Full Text] [Related]
6. Higher-dose, more frequent treatment of Wuchereria bancrofti.
Kazura JW
Clin Infect Dis; 2010 Dec; 51(11):1236-7. PubMed ID: 21039221
[No Abstract] [Full Text] [Related]
7. Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years.
Sunish IP; Rajendran R; Mani TR; Munirathinam A; Reuben R; Dash AP
Parasitol Int; 2006 Sep; 55(3):233-6. PubMed ID: 16807079
[TBL] [Abstract][Full Text] [Related]
8. Use of high-dose, twice-yearly albendazole and ivermectin to suppress Wuchereria bancrofti microfilarial levels.
Dembele B; Coulibaly YI; Dolo H; Konate S; Coulibaly SY; Sanogo D; Soumaoro L; Coulibaly ME; Doumbia SS; Diallo AA; Traore SF; Diaman Keita A; Fay MP; Nutman TB; Klion AD
Clin Infect Dis; 2010 Dec; 51(11):1229-35. PubMed ID: 21039220
[TBL] [Abstract][Full Text] [Related]
9. Filariasis elimination, Zanzibar.
Wkly Epidemiol Rec; 2001 Dec; 76(51-52):406-8. PubMed ID: 11789061
[No Abstract] [Full Text] [Related]
10. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
11. A review of epidemiology of lymphatic filariasis in Nigeria.
Waje T; Iliyasu C; Yaki LM; Auta IK
Pan Afr Med J; 2024; 47():142. PubMed ID: 38933431
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of lymphatic filariasis by a double dose].
Boureé P
Med Sante Trop; 2014; 24(3):254-5. PubMed ID: 25580494
[No Abstract] [Full Text] [Related]
13. Report on active surveillance for adverse events following the use of drug co-administrations in the global programme to eliminate lymphatic filariasis.
Wkly Epidemiol Rec; 2003 Sep; 78(36):315-7. PubMed ID: 14518107
[No Abstract] [Full Text] [Related]
14. A Trial of a Triple-Drug Treatment for Lymphatic Filariasis.
King CL; Suamani J; Sanuku N; Cheng YC; Satofan S; Mancuso B; Goss CW; Robinson LJ; Siba PM; Weil GJ; Kazura JW
N Engl J Med; 2018 Nov; 379(19):1801-1810. PubMed ID: 30403937
[TBL] [Abstract][Full Text] [Related]
15. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
16. Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
Sahoo PK; Satapathy AK; Michael E; Ravindran B
Am J Trop Med Hyg; 2005 Nov; 73(5):877-80. PubMed ID: 16282297
[TBL] [Abstract][Full Text] [Related]
17. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.
Dunyo SK; Nkrumah FK; Simonsen PE
Trans R Soc Trop Med Hyg; 2000; 94(2):205-11. PubMed ID: 10897370
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of post-treatment reactions to ivermectin/albendazole for Wuchereria bancrofti in a region co-endemic for Mansonella perstans.
Keiser PB; Coulibaly YI; Keita F; Traore D; Diallo A; Diallo DA; Semnani RT; Doumbo OK; Traore SF; Klion AD; Nutman TB
Am J Trop Med Hyg; 2003 Sep; 69(3):331-5. PubMed ID: 14628953
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
Kroidl I; Saathof E; Maganga L; Clowes P; Maboko L; Hoerauf A; Makunde WH; Haule A; Mviombo P; Pitter B; Mgeni N; Mabuye J; Kowuor D; Mwingira U; Malecela MN; Löscher T; Hoelscher M
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004618. PubMed ID: 27070786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
